Ken Fisher Puma Biotechnology, Inc. Transaction History

Fisher Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$6.28 - $14.57 $186,811 - $433,413	-29,747 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$6.5 - $10.73 $95,693 - $157,967	-14,722 Reduced 33.11%	29,747 $260,000
Q2 2019 Jul 30, 2019	BUY	$12.3 - $35.76 $352,800 - $1.03 Million	28,683 Added 181.7%	44,469 $565,000
Q1 2018 May 11, 2018	SELL	$59.7 - $99.25 $1.33 Million - $2.22 Million	-22,330 Reduced 58.58%	15,786 $1.07 Million
Q1 2018 Apr 19, 2018	BUY	$59.7 - $99.25 $1.3 Million - $2.16 Million	21,730 Added 132.61%	38,116 $2.59 Million
Q4 2017 Jan 24, 2018	BUY	$93.85 - $132.45 $78,927 - $111,390	841 Added 5.41%	16,386 $1.62 Million
Q3 2017 Oct 17, 2017	BUY	$72.0 - $119.75 $1.12 Million - $1.86 Million	15,545	15,545 $1.86 Million

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.